You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 145 No. 6, June 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (31)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Amiodarone-Induced Hypothyroidism

A Common Complication of Prolonged Therapy: A Report of Eight Cases

Gillian C. Hawthorne, MB, MRCP; Norman P. S. Campbell, MD, MRCP; John S. Geddes, BSc, MD, FRCP, FACC; W. Rodney Ferguson, MSc, PhD; William Postlethwaite, FIMLS, MSc; Brian Sheridan, BA, MSc; A. Brew Atkinson, BSc, MD, MRCP

Arch Intern Med. 1985;145(6):1016-1019.


Abstract

• Amiodarone is a widely used antiarrhythmic drug, which contains 75 mg of iodide per 200 mg of active substance. Eight of our patients receiving long-term amiodarone therapy became hypothyroid. Seven of these patients had no previous history of thyroid dysfunction or goiter. Antithyroid antibodies were absent, and standard perchlorate discharge tests were positive in seven patients when hypothyroidism was diagnosed. In one patient, amiodarone therapy was withdrawn; over the next nine months, the hypothyroidism resolved, and results of the perchlorate discharge test reverted to normal. We conclude that amiodarone-induced hypothyroidism is similar to previously described iodide-induced hypothyroidism. It may develop in the absence of a previous history of thyroid disease, and all patients receiving long-term amiodarone therapy should therefore be regularly monitored for hypothyroidism.

(Arch Intern Med 1985;145:1016-1019)



Author Affiliations

From the Sir George E. Clark Metabolic Unit (Drs Hawthorne and Atkinson), the Regional Medical Cardiology Centre (Drs Campbell and Geddes), the Regional Endocrine Laboratory (Drs Postlethwaite and Sheridan), and the Regional Medical Physics Service (Dr Ferguson), Royal Victoria Hospital, Belfast.


Footnotes

Accepted for publication Sept 21, 1984.

Reprint requests to the Sir George E. Clark Metabolic Unit, Royal Victoria Hospital, Grosvenor Rd, Belfast, BT12 6BA, Northern Ireland (Dr Atkinson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Effects of Amiodarone on the Thyroid
Martino et al.
Endocr. Rev. 2001;22:240-254.
ABSTRACT | FULL TEXT  

Perchlorate and the Thyroid Gland
Wolff
Pharmacol. Rev. 1998;50:89-106.
ABSTRACT | FULL TEXT  

Tumor-Promoting Effects of Both Iodine Deficiency and Iodine Excess in the Rat Thyroid
Kanno et al.
Toxicol Pathol 1992;20:226-235.
ABSTRACT  

Serum Sex Hormone--Binding Globulin in Amiodarone-Treated Patients: A Marker for Tissue Thyrotoxicosis
Bambini et al.
Arch Intern Med 1987;147:1781-1785.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.